Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primatesStéphane Pillet, Brian J. Ward|Cellular and Molecular Immunology|2022Cited by 59
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophagesА. И. Макарков, Brian J. Ward|npj Vaccines|2019Cited by 42
Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunityHilary E. Hendin, Brian J. Ward|npj Vaccines|2022Cited by 16